Literature DB >> 18619944

Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients.

Kazuhiro Tanabe1, Akihiro Deguchi, Mikito Higashi, Hisashi Usuki, Yasuyuki Suzuki, Youichi Uchimura, Shigeki Kuriyama, Kazuhiro Ikenaka.   

Abstract

Serum glycans are promising markers for early-stage cancer detection, but the research remains challenging because low concentrations of serum glycoproteins are secreted from early-stage tumors. We have established an N-glycan profiling method using liquid chromatography electrospray ionization-mass spectrometry with high sensitive derivative, trimethyl(4-aminophenyl)ammonium chloride (TMAPA). The mass sensitivity of TMAPA-labeled oligosaccharides was enhanced more than 50 times compared with 2-aminopyridine (PA) labeled oligosaccharides, and the analytical period was significantly shortened compared with traditional HPLC 2D-mapping. Using this method, we found about 28 major N-linked oligosaccharides in human sera, and we investigated their alterations in patients who developed hepatocellular carcinoma (HCC). We found that outer arm fucosylation (attached GlcNAc via an alpha 1-3/4 linkage) in highly branched oligosaccharides increased significantly in sera of HCC patients. Normalizing the level of outer arm fucosylation by taking into account platelet concentration allowed us to distinguish more clearly between HCC and LC patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619944     DOI: 10.1016/j.bbrc.2008.06.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans.

Authors:  Patrick R Romano; Andrew Mackay; Minh Vong; Johann DeSa; Anne Lamontagne; Mary Ann Comunale; Julie Hafner; Timothy Block; Ryszard Lec; Anand Mehta
Journal:  Biochem Biophys Res Commun       Date:  2011-09-14       Impact factor: 3.575

2.  Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.

Authors:  Ioan Marginean; Scott R Kronewitter; Ronald J Moore; Gordon W Slysz; Matthew E Monroe; Gordon Anderson; Keqi Tang; Richard D Smith
Journal:  Anal Chem       Date:  2012-10-17       Impact factor: 6.986

Review 3.  Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

Authors:  Jianhui Zhu; Elisa Warner; Neehar D Parikh; David M Lubman
Journal:  Mass Spectrom Rev       Date:  2018-11-25       Impact factor: 10.946

Review 4.  Glycomics and disease markers.

Authors:  Hyun Joo An; Scott R Kronewitter; Maria Lorna A de Leoz; Carlito B Lebrilla
Journal:  Curr Opin Chem Biol       Date:  2009-09-21       Impact factor: 8.822

5.  Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.

Authors:  Eva Åström; Per Stål; Robin Zenlander; Pia Edenvik; Catharina Alexandersson; Mats Haglund; Ingvar Rydén; Peter Påhlsson
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

6.  LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.

Authors:  Tsung-Heng Tsai; Minkun Wang; Cristina Di Poto; Yunli Hu; Shiyue Zhou; Yi Zhao; Rency S Varghese; Yue Luo; Mahlet G Tadesse; Dina Hazem Ziada; Chirag S Desai; Kirti Shetty; Yehia Mechref; Habtom W Ressom
Journal:  J Proteome Res       Date:  2014-08-08       Impact factor: 4.466

7.  Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease.

Authors:  Julius Benicky; Miloslav Sanda; Petr Pompach; Jing Wu; Radoslav Goldman
Journal:  Anal Chem       Date:  2014-10-24       Impact factor: 6.986

8.  Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.

Authors:  Eiji Shinozaki; Kazuhiro Tanabe; Takashi Akiyoshi; Tomohiro Tsuchida; Yuko Miyazaki; Nozomi Kojima; Masahiro Igarashi; Masashi Ueno; Mitsukuni Suenaga; Nobuyuki Mizunuma; Kensei Yamaguchi; Konosuke Nakayama; Sadayo Iijima; Toshiharu Yamaguchi
Journal:  BMC Cancer       Date:  2018-04-11       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.